Algert Global LLC Passage Bio, Inc. Transaction History

Algert Global LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.63 - $3.46 $5,069 - $10,760	-3,110 Reduced 3.91%	76,360 $180,000
Q1 2022 May 16, 2022	BUY	$2.66 - $6.49 $10,517 - $25,661	3,954 Added 5.24%	79,470 $246,000
Q4 2021 Feb 14, 2022	BUY	$6.24 - $10.2 $346,070 - $565,692	55,460 Added 276.53%	75,516 $480,000
Q3 2021 Nov 15, 2021	BUY	$9.73 - $15.52 $195,144 - $311,269	20,056 New	20,056 $200,000

38.7M

7.7K

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $32.1M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.